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The Beijing lineage of *Mycobacterium tuberculosis* (also referred to as the East Asian lineage or lineage 2) is an emerging public health threat ([@R-2-1],[@R-2-2]). The Beijing lineage accounts for 13% of *M. tuberculosis* strains globally ([@R-2-3]) and 19%--27% of *M. tuberculosis* strains in low tuberculosis (TB) incidence immigrant-receiving countries, such as Australia, the United States, and Canada ([@R-2-4]--[@R-2-6]). In addition to their recent global dissemination, Beijing lineage strains raise concern because of frequent associations with drug resistance and multidrug-resistant TB in particular ([@R-2-1],[@R-2-6]--[@R-2-8]). Reports of Beijing strains that are extensively drug resistant further intensify these concerns ([@R-2-7]).

The rapid global expansion of Beijing strains and their frequent (albeit inconsistent) association with large TB outbreaks and younger patients has led to speculation that Beijing strains have a selective advantage over other *M. tuberculosis* lineages as conferred through increased transmissibility and virulence ([@R-2-1],[@R-2-2],[@R-2-7]). This hypothesis is supported by experimental evidence of the increased virulence of Beijing lineage strains relative to other *M. tuberculosis* strains in vitro and in animal models ([@R-2-9],[@R-2-10]). Evidence also suggests that the fitness of some Beijing strains is retained after the acquisition of drug resistance ([@R-2-11]). Nevertheless, intragenotypic variation in virulence has been described in the Beijing family ([@R-2-12],[@R-2-13]) and, in a review, Coscolla and Gagneux ([@R-2-14]) concluded that the current body of evidence is insufficient to support the increased transmissibility of these strains.

Immigration is the main determinant of TB epidemiology in low incidence settings ([@R-2-15],[@R-2-16]). Consequently, the importation of potentially more pathogenic strains, such as those in the Beijing family, could have major implications for TB prevention and elimination efforts within immigrant-receiving countries. Surveillance activities that identify the sources and transmission patterns of emerging and/or expanding *M. tuberculosis* strains will be increasingly vital if TB prevention and care programs are to maintain their effectiveness within the context of dynamic immigration policies and highly mobile populations.

We aimed to investigate the association of Beijing and non-Beijing lineage strains with transmission in a low TB incidence immigrant-receiving province of Canada. In particular, we sought to determine whether the Beijing lineage of *M. tuberculosis* is a greater public health threat than other strains because of increased transmission leading to disease.

Methods
=======

Study Setting and Population
----------------------------

Culture-confirmed pulmonary TB cases (potential transmitters) in the province of Alberta, Canada, during January 1, 1991--June 30, 2007 (i.e., study period) in accordance with the provincial TB registry were eligible for inclusion in this population-based retrospective study (see Transmission Leading to Disease below for additional criteria). These cases represent the pulmonary subset of previously reported cases ([@R-2-6]). Ethics approval was received from the University of Alberta Health Research Ethics Board, and analysis of surveillance data did not require informed consent because there was no direct patient contact.

Persons born in Canada or born outside of Canada to Canadian-born parents were considered Canadian-born; all others were foreign-born. The Canadian-born population was not further categorized into Aboriginal and non-Aboriginal groups because only 5 Beijing TB cases occurred among Aboriginal peoples during the study period ([@R-2-6]). However, because of the high prevalence of Beijing strains in parts of Southeast and East Asia ([@R-2-1]), country of birth was used to group foreign-born persons into those born in the Western Pacific region and those born elsewhere ([@R-2-16]).

Case Characteristics
--------------------

Demographic and clinical data from the TB Registry were combined with data from the Provincial Laboratory for Public Health (Provincial Laboratory). The Provincial Laboratory conducts all mycobacteriology studies in the province in accordance with the Canadian Tuberculosis Standards ([@R-2-17]).

Sputum smear status and the presence or absence of lung cavitation on chest radiograph were used as indicators of infectiousness. Baseline sputum smears collected on, or within the week before, the date of diagnosis (the start date of treatment) that had grade 3+ to 4+ scores for acid-fast bacilli were categorized as having high bacillary loads ([@R-2-17]). Monoresistant isolates had resistance to a single first-line drug, namely isoniazid, rifampin, pyrazinamide, ethambutol, or streptomycin ([@R-2-17]). Resistance to [\>]{.ul}2 first-line drugs but without isoniazid--rifampin resistance constituted polyresistance, whereas multidrug-resistant TB comprised cases with resistance to at least isoniazid--rifampin.

The Provincial Laboratory completed DNA fingerprinting of prospectively archived isolates with the IS*6110* restriction fragment-length polymorphism (RFLP) method, and for isolates with [\<]{.ul}5 copies of IS*6110*, spoligotyping was performed as described ([@R-2-18]). Isolates were also assigned to an *M. tuberculosis* lineage at the Provincial Laboratory according to the PCR-based detection of large sequence polymorphisms as described ([@R-2-19],[@R-2-20]). Isolates with a deletion of RD105 were classified as Beijing lineage strains and all others as non-Beijing lineage strains.

Transmission Leading to Disease
-------------------------------

Of the 1,399 eligible pulmonary TB cases during the study period, 20 (1%) were excluded because either the DNA fingerprint pattern or *M. tuberculosis* lineage could not be determined. The remaining 1,379 cases were included in an analysis of clustering to provide an indication of overall transmission leading to disease during the study period. A cluster was defined as [\>]{.ul}2 patients whose case isolates had identical DNA fingerprints.

In addition to overall transmission, recent transmission that led to disease was quantified to account for dissimilarities in the follow-up periods of potential source cases and to minimize the probability of propagated transmission by second and later generation source cases ([@R-2-21]). A Kaplan-Meier survival analysis was completed with the 1,379 pulmonary TB cases to determine the cutoff point for the definition of recent transmission ([@R-2-21],[@R-2-22]). The Kaplan-Meier probability of an isolate being followed by another isolate with an identical fingerprint pattern during the 16.5-year study period was 0.36; the probability of [\>]{.ul}2 isolates having identical fingerprint patterns in a 2- and 3-year period was 0.22 and 0.24, respectively (online Technical Appendix, [wwwnc.cdc.gov/EID/article/19/5/12-1578-Techapp1.pdf](http://wwwnc.cdc.gov/EID/article/19/5/12-1578-Techapp1.pdf)). Given the similarity in these latter probabilities, the 2-year period was subsequently determined to be the ideal cutoff period because it coincided with the conventional high-risk period for the development of active TB after recent infection (18--24 months) ([@R-2-17]).

Using the 2-year cutoff point, we defined an index case as a pulmonary TB case with a DNA fingerprint pattern that had not been assigned to another case within the preceding 2 years. A secondary case was any case that had an identical fingerprint pattern as an index case provided that it was also diagnosed no more than 2 years after the index case. Using these definitions, we excluded 430 (31%) of 1,379 TB cases from the analysis of recent transmission. Specifically, 167 index cases diagnosed during 1991--1992 and their 50 secondary cases were excluded because we could not determine whether the fingerprint patterns of the index cases matched another case in the preceding 2 years. Follow-up periods of \<2 years resulted in the exclusion of an additional 124 index cases diagnosed after June 2005 and their 10 secondary cases. Finally, 79 secondary cases were excluded because of diagnosis \>2 years after the index case but \<2 years after another cluster member. After these exclusions, 949 (69%) cases diagnosed during January 1, 1993--June 30, 2007, were included in the primary analysis of recent transmission.

Statistical Analysis
--------------------

We analyzed data using Stata/IC 11 (StataCorp LP, College Station, TX, USA). For overall transmission, associations between case characteristics and *M. tuberculosis* lineage were assessed with bivariate and multivariate logistic regression analyses at a 5% level of significance. Characteristics of case-patients (sex, age at diagnosis, population group, sputum smear status, bacillary load, lung cavitation, drug resistance and clustering) that were p\<0.2 in bivariate analyses were eligible for inclusion in the multivariate model. Subgroup analyses were also completed to evaluate intragenotypic associations between clustering and case-patient characteristics by using bivariate and multivariate logistic regression analyses.

For the analyses of recent transmission, transmission indices were calculated as the total number of secondary cases within the cutoff period divided by the total number of index cases ([@R-2-21]). The risk factors of index cases that were associated with recent transmission leading to disease (i.e., relative transmission indices) were assessed with bivariate and multivariate Poisson regression by using an offset of 1 for each index case ([@R-2-21]). Specifically, associations with sex, age at diagnosis, population group, sputum smear status, bacillary load, lung cavitation, drug resistance, and *M. tuberculosis* lineage were initially analyzed with bivariate Poisson regression. Multivariate Poisson regression modeling was constructed with purposeful selection and, with the exception of *M. tuberculosis* lineage, variables that had p\<0.20 in bivariate regression were included in the initial multivariate model. As the primary variable of interest in this study, *M. tuberculosis* lineage was included in all multivariate models regardless of its significance.

For all multivariate regression modeling, the confounding effects of removed variables (p[\>]{.ul}0.05) were assessed with the percentage rule. We used a collapsibility criterion [\<]{.ul}15%, and the significance of potential interactions was based on the partial likelihood ratio test ([@R-2-23]).

We assessed the influence of the length of the cutoff period on recent transmission with sensitivity analyses using 3- and 5-year cutoff periods. Additional analysis was completed with no cutoff period, the index case for each fingerprint pattern being the isolate in the dataset with the earliest date of diagnosis. We also evaluated the potential effect of including nonpulmonary secondary cases in the analysis of recent transmission. For this latter analysis, all nonpulmonary TB cases registered in Alberta during the study period that had an identical DNA fingerprint as a pulmonary index case were eligible for study inclusion.

Results
=======

We identified Beijing strains in 258 (19%) of the 1,379 pulmonary TB cases in 1991--2007. Compared with non-Beijing cases, Beijing cases occurred among persons of similar sex and age but more often foreign-born (p\<0.0001) ([Table 1](#T-2-1){ref-type="table"}). The infectiousness of Beijing and non-Beijing cases was similar in relation to sputum smear status, bacillary load, and presence/absence of lung cavitation ([Table 1](#T-2-1){ref-type="table"}). *M. tuberculosis* lineage and drug resistance were not independently associated ([Table 1](#T-2-1){ref-type="table"}).

###### Characteristics of persons with pulmonary TB associated with *Mycobacterium tuberculosis* Beijing and non-Beijing strains, Alberta, Canada, 1991--2007

  Characteristic                  Strain                        OR (95% CI)\*                           
  ------------------------------- ------------- --------------- --------------- ----------------------- -----------------------
  Sex                                                                                                   
  F                               100 (38.8)    492 (43.9)                      1.0                     1.0
  M                               158 (61.2)    629 (56.1)                      1.2 (0.9--1.6)          1.3 (0.9--1.8)
  Age at diagnosis, y                                                                                   
  \<35                            72 (27.9)     319 (28.5)                      1.0                     1.0
  35--64                          69 (26.7)     421 (37.6)                      0.7 (0.5--1.04)         0.7 (0.1--1.01)
  \>64                            117 (45.3)    381 (34.0)                      1.4 (0.98--1.9)         1.1 (0.7--1.6)
  Population group                                                                                      
  Canadian-born                   19 (7.4)      520 (46.4)                      1.0                     1.0
  Foreign-born, other             26 (10.1)     346 (30.9)                      **2.1 (1.1--3.8)**      **2.1 (1.1--4.1)**
  Foreign-born, Western Pacific   213 (82.6)    255 (22.7)                      **22.9 (14.0--37.4)**   **22.6 (13.1--39.2)**
  Sputum smear status†                                                                                  
  Negative                        132 (54.1)    517 (49.0)                      1.0                     1.0
  Positive                        112 (45.9)    538 (51.0)                      0.8 (0.6--1.1)          1.2 (0.8--1.7)
  Bacillary load‡§                                                                                      
  Low                             38 (70.4)     177 (66.5)                      1.0                     
  High                            16 (29.6)     89 (33.5)                       0.8 (0.4--1.6)          
  Results of chest radiography                                                                          
  No cavitation                   206 (79.8)    853 (76.1)                      1.0                     1.0
  Cavitation                      52 (20.2)     268 (23.9)                      0.8 (0.6--1.1)          0.8 (0.5--1.3)
  Drug resistance                                                                                       
  Pan-susceptible                 202 (78.3)    1000 (89.2)                     1.0                     1.0
  Monoresistance                  30 (11.6)     90 (8.0)                        **1.7 (1.1--2.6)**      0.8 (0.5--1.3)
  Polyresistance                  20 (7.8)      25 (2.2)                        **4.0 (2.2--7.3)**      1.7 (0.9--3.5)
  Multidrug resistance            6 (2.3)       6 (0.5)                         **5.0 (1.6--15.5)**     3.7 (0.9--14.7)
  Clustering                                                                                            
  Nonclustered                    203 (78.7)    703 (62.7)                      1.0                     1.0
  Clustered                       55 (21.3)     418 (37.3)                      **0.5 (0.3--0.6)**      0.8 (0.6--1.3)
  Total                           258 (100.0)   1,121 (100.0)                                           

\***Boldface** indicates significance (p\<0.05). TB, tuberculosis; OR, odds ratio.  †Sputum smear microscopy was not completed for all cases. ‡Semiquantitative scores for acid-fast bacilli load on the baseline sputum smear. Positive smears with semiquantitative scores of 3+ or 4+ were categorized as having high bacillary load; all remaining positive smears were labeled as having a low bacillary load. §Bacillary load was not included in multivariate modeling because of multicollinearity with sputum smear status.

Overall Transmission
--------------------

Overall, 906 (66%) cases exhibited unique fingerprint patterns (nonclustered cases), and 473 (34%) clustered cases were dispersed among 119 clusters. Of Beijing cases, 203 (79%) were nonclustered, and 55 (21%) were distributed among 22 clusters. Non-Beijing cases accounted for the remaining 703 (63%) nonclustered cases and 418 (37%) clustered cases within 97 clusters. Beijing cases were half as likely as non-Beijing cases to be clustered (p\<0.0001), but this difference disappeared after we controlled for demographic characteristics, infectiousness, and drug resistance (p = 0.405) ([Table 1](#T-2-1){ref-type="table"}).

Intragenotypic analysis showed that the clustering of Beijing cases was not associated with demographic characteristics, infectiousness, or drug resistance ([Table 2](#T-2-2){ref-type="table"}). In contrast, the likelihood of non-Beijing cases being clustered was significantly less when patients were \>64 years of age at diagnosis (vs. \<35 years; p\<0.0001) or foreign-born (p\<0.0001) ([Table 2](#T-2-2){ref-type="table"}). Although resistance to a single first-line anti-TB drug appeared to be associated with less clustering in bivariate analysis (p = 0.001), it was not associated with clustering independent of sex, age at diagnosis, and population group (p = 0.102) ([Table 2](#T-2-2){ref-type="table"}).

###### Case-patient characteristics associated with clustering of Beijing and non-Beijing *Mycobacterium tuberculosis* lineages, Alberta, Canada, 1991--2007

  Characteristic                  All cases   No. (%) clustered cases   OR (95% CI)\*           
  ------------------------------- ----------- ------------------------- ----------------------- -----------------------
  Beijing                                                                                       
  Sex                                                                                           
  F                               100         19 (19.0)                 1.0                     
  M                               158         36 (22.8)                 1.3 (0.7--2.3)          
  Age at diagnosis, y                                                                           
  \<35                            72          17 (23.6)                 1.0                     1.0
  35--64                          69          19 (27.5)                 1.2 (0.6--2.6)          1.3 (0.6--2.8)
  \>64                            117         19 (16.2)                 0.6 (0.3--1.3)          0.7 (0.3--1.5)
  Population group                                                                              
  Canadian-born                   19          7 (36.8)                  1.0                     
  Foreign-born, other             26          6 (23.1)                  0.5 (0.1--1.9)          
  Foreign-born, Western Pacific   213         42 (19.7)                 0.4 (0.2--1.1)          
  Sputum smear status                                                                           
  Negative                        132         26 (19.7)                 1.0                     
  Positive                        112         25 (22.3)                 1.2 (0.6--2.2)          
  Bacillary load                                                                                
  Low                             38          7 (18.4)                  1.0                     
  High                            16          6 (37.5)                  2.7 (0.7--9.8)          
  Chest radiography                                                                             
  No cavitation                   206         40 (19.4)                 1.0                     1.0
  Cavitation                      52          15 (28.8)                 1.7 (0.8--3.4)          1.6 (0.8--3.2)
  Drug resistance                                                                               
  Pan-susceptible                 202         42 (20.8)                 1.0                     
  Monoresistance                  30          7 (23.3)                  1.2 (0.5--2.9)          
  Polyresistance                  20          6 (30.0)                  1.6 (0.6--4.5)          
  Multidrug resistance            6           0                         NA                      
  Non-Beijing                                                                                   
  Sex                                                                                           
  F                               492         168 (34.1)                1.0                     1.0
  M                               629         250 (39.7)                1.3 (0.98--1.6)         1.1 (0.8, 1.4)
  Age at diagnosis, y                                                                           
  \<35                            319         134 (42.0)                1.0                     1.0
  35--64                          421         182 (43.2)                1.1 (0.8--1.4)          0.8 (0.5--1.1)
  \>64                            381         102 (26.8)                **0.5 (0.4--0.7)**      **0.4 (0.3--0.6)**
  Population group                                                                              
  Canadian-born                   520         316 (60.8)                1.0                     1.0
  Foreign-born, other             346         42 (12.1)                 **0. 1 (0.06--0.13)**   **0.09 (0.06--0.13)**
  Foreign-born, Western Pacific   255         60 (23.5)                 **0.20 (0.14--0.28)**   **0.21 (0.15--0.31)**
  Sputum smear status                                                                           
  Negative                        517         198 (38.3)                1.0                     
  Positive                        538         199 (37.0)                0.9 (0.7--1.2)          
  Bacillary load                                                                                
  Low                             177         67 (37.9)                 1.0                     
  High                            89          39 (43.8)                 1.3 (0.8--2.1)          
  Chest radiography                                                                             
  No cavitation                   853         312 (36.6)                1.0                     
  Cavitation                      268         106 (39.6)                1.1 (0.9--1.5)          
  Drug resistance                                                                               
  Pan-susceptible                 1,000       393 (39.3)                1.0                     1.0
  Monoresistance                  90          19 (21.1)                 **0.4 (0.2--0.7)**      0.6 (0.4--1.1)
  Polyresistance                  25          5 (20.0)                  0.4 (0.1--1.04)         0.7 (0.3--2.1)
  Multidrug resistance            6           1 (16.7)                  0.3 (0.04--2.7)         0.5 (0.05--5.0)

\***Boldface** indicates significance (p\<0.05). OR, odds ratio.  †Multivariate analysis was based on purposeful selection with variables with p\<0.2 in unadjusted analyses being included in the multivariate model. For Beijing strains, multivariate analysis included the independent variables of age at diagnosis and chest radiography. Sex, age at diagnosis, population group, and drug resistance were the independent variables in the multivariate analysis for non-Beijing strains.

In each lineage group, the number of nonclustered TB cases in foreign-born persons was inversely associated with time since arrival, such that 30%--32% of these cases occurred within the first 2 years after arrival ([Figure](#F1){ref-type="fig"}). Clustered cases appeared to follow a similar pattern ([Figure](#F1){ref-type="fig"}), although interpretation was limited by the relatively small number of cases.

![Number of clustered and nonclustered cases according to *Mycobacterium tuberculosis* lineage among foreign-born persons and time since arrival in Alberta, Canada, 1991--2007. A) Beijing cases; B) Non-Beijing cases. Gray bars, nonclustered cases; black bars, clustered cases.](12-1578-F){#F1}

Recent Transmission
-------------------

Cases excluded from the analysis of recent transmission were demographically and clinically similar to included cases (data not shown). On average, an index case resulted in 0.13 secondary cases within 2 years. In unadjusted analysis, the number of secondary cases was higher if the index case-patient was sputum smear positive, had a high bacillary load, or had lung cavitation ([Table 3](#T-2-3){ref-type="table"}). Conversely, fewer secondary cases were associated with index case-patients who were \>64 years of age (vs. \<35 years), foreign-born, or infected with Beijing strains. In adjusted analysis, the number of secondary cases was associated with the age, population group, and smear status of the index case-patients ([Table 3](#T-2-3){ref-type="table"}). Specifically, fewer secondary cases occurred if the index case-patient was \>64 years of age (vs. \<35 years) or foreign-born whereas an increased number of secondary cases was associated with sputum smear--positive index case-patients ([Table 3](#T-2-3){ref-type="table"}). The lineage of *M. tuberculosis* was not independently associated with the number of secondary cases.

###### Risk factors for the recent transmission of *Mycobacterium tuberculosis*, Alberta, Canada, 1993--2007

  Characteristic                  Index case-patient   Secondary case-patient   Transmission index\*   Relative transmission index (95% CI)†                         
  ------------------------------- -------------------- ------------------------ ---------------------- --------------------------------------- --------------------- ---------------------
  Sex                                                                                                                                                                
  F                               330                  29                       38                     0.11                                    1.0                   
  M                               440                  44                       68                     0.14                                    1.3 (0.9--2.0)        
  Age at diagnosis, y                                                                                                                                                
  \<35                            185                  17                       30                     0.15                                    1.0                   1.0
  35--64                          277                  35                       47                     0.15                                    1.0 (0.6--1.6)        0.6 (0.4--1.0)‡
  \>64                            308                  21                       29                     0.09                                    **0.6 (0.4--1.0)**§   **0.4 (0.3--0.7)**
  Population group                                                                                                                                                   
  Canadian-born                   210                  46                       77                     0.30                                    1.0                   1.0
  Foreign-born, other             243                  9                        9                      0.04                                    **0.1 (0.1--0.2)**    **0.1 (0.1--0.2)**
  Foreign-born, Western Pacific   317                  18                       20                     0.06                                    **0.2 (0.1--0.3)**    **0.2 (0.1--0.3)**
  Sputum smear status§                                                                                                                                               
  Negative                        364                  25                       36                     0.09                                    1.0                   1.0
  Positive                        357                  46                       68                     0.17                                    **1.8 (1.2--2.7)**    **1.6 (1.0--2.3)¶**
  Bacillary load\#                                                                                                                                                   
  Low                             134                  15                       25                     0.17                                    1.0                   
  High                            56                   15                       23                     0.32                                    **1.9 (1.1--3.4)**    
  Chest radiography                                                                                                                                                  
  No cavitation                   596                  44                       65                     0.10                                    1.0                   
  Cavitation                      174                  29                       41                     0.20                                    **2.0 (1.3--2.9)**    
  Drug resistance                                                                                                                                                    
  Pan-susceptible                 660                  66                       98                     0.13                                    1.0                   
  Monoresistance                  72                   4                        4                      0.05                                    0.4 (0.1--1.1)        
  Polyresistance                  28                   3                        4                      0.13                                    1.0 (0.4--2.6)        
  Multidrug resistance\*\*        10                   0                        0                      0.00                                                          
  *M. tuberculosis* strain                                                                                                                                           
  Non-Beijing                     597                  61                       94                     0.14                                    1.0                   0.8 (0.4--1.7)
  Beijing                         173                  12                       12                     0.06                                    **0.5 (0.2--0.8)**    
  Total                           770                  73                       106                    0.13                                                          

\*The number of secondary cases divided by the number of index cases †Bivariate and multivariate Poisson regression models used an offset of 1 each index case. Variables with p\<0.20 in bivariate analysis were eligible for inclusion in the multivariate model.**Boldface** indicates significance (p\<0.05). ‡p = 0.058. §Sputum smear microscopy was not completed for all cases. ¶p = 0.037. \#Bacillary load was not included in multivariate modeling because of multicollinearity with sputum smear status. \*\*Multidrug-resistant TB was excluded from bivariate and multivariate analyses.

In subgroup analyses of foreign-born index case-patients, the number of secondary cases per index case-patient was unrelated to the length of residency in Canada. For example, compared with index case-patients who were [\<]{.ul}2 years since arrival, the relative transmission indices of those 3--5 years and those \>20 years since arrival were 1.1 (95% CI 0.3--4.1) and 1.2 (95% CI 0.4--3.6), respectively. Among persons born in the Western Pacific, no risk factors for the number of secondary cases within 2 years per index case-patient were identified, including age, *M. tuberculosis* lineage, or time since arrival ([Table 4](#T-2-4){ref-type="table"}).

###### Risk factors for the recent transmission of *Mycobacterium tuberculosis* among index case-patients born in Alberta, Canada, in the Western Pacific, 1993--2007

  Characteristic                    Index case-patients   Secondary case-patients   Transmission index\*   Relative transmission index (95% CI)†                     
  --------------------------------- --------------------- ------------------------- ---------------------- --------------------------------------- ----------------- ----------------
  Sex                                                                                                                                                                
  F                                 122                   9                         10                     0.08                                    1.0               
  M                                 195                   9                         10                     0.05                                    0.6 (0.3--1.5)    
  Age at diagnosis, y                                                                                                                                                
  \<35                              83                    5                         5                      0.06                                    1.0               
  35--64                            110                   4                         4                      0.04                                    0.6 (0.2--2.3)    
  \>64                              124                   9                         11                     0.08                                    1.5 (0.5--4.2)    
  Sputum smear status‡                                                                                                                                               
  Negative                          174                   7                         7                      0.04                                    1.0               1.0
  Positive                          126                   9                         11                     0.08                                    2.1 (0.8--5.4)    2.1 (0.8--5.5)
  Bacillary load§                                                                                                                                                    
  Low                               53                    3                         5                      0.09                                    1.0               
  High                              17                    1                         1                      0.06                                    0.6 (0.1--5.3)    
  Chest radiography                                                                                                                                                  
  No cavitation                     252                   14                        16                     0.06                                    1.0               
  Cavitation                        65                    4                         4                      0.06                                    1.0 (0.3--2.9)    
  Drug resistance                                                                                                                                                    
  Pan-susceptible                   239                   13                        14                     0.06                                    1.0               
  Monoresistance                    51                    2                         2                      0.04                                    0.7 (0.2--3.0)    
  Polyresistance                    21                    3                         4                      0.17                                    3.0 (1.0--9.1)    
  Multidrug resistance¶             6                     0                         0                      0                                                         
  *M. tuberculosis* lineage                                                                                                                                          
  Non-Beijing                       171                   9                         11                     0.06                                    1.0               1.0
  Beijing                           146                   9                         9                      0.06                                    1.0 (0.4--2.3)    0.9 (0.3--2.2)
  Time since arrival in Canada, y                                                                                                                                    
  [\<]{.ul}2                        76                    3                         3                      0.04                                    1.0               
  3--5                              43                    1                         1                      0.02                                    0.6 (0.1--5.8)    
  6--10                             53                    6                         6                      0.10                                    2.7 (0.7--10.7)   
  \>10                              112                   8                         10                     0.08                                    2.2 (0.6--8.0)    
  Total                             317                   18                        20                     0.06                                                      

\*The number of secondary cases divided by the number of index cases. †Bivariate Poisson regression using an offset of 1 each index case. ‡Sputum smear microscopy was not completed with all cases. §Bacillary load was not included in multivariate modeling because of multicollinearity with sputum smear status. ¶Multidrug-resistant tuberculosis was excluded from bivariate analyses.

Sensitivity analyses demonstrated that longer cutoff periods produced higher transmission indices among Beijing cases and non-Beijing cases ([Table 5](#T-2-5){ref-type="table"}). Although Beijing index cases had significantly fewer secondary cases than did non-Beijing index cases regardless of the length of the cutoff period, *M. tuberculosis* lineage was not associated with the number of secondary cases within a 2-, 3-, or 5-year cutoff period after we controlled for demographic characteristics and infectiousness. Beijing index cases had significantly fewer secondary cases than did non-Beijing cases independent of other factors when a cutoff period was not defined (equivalent to overall transmission). Inclusion of nonpulmonary secondary cases also increased the transmission indices of Beijing and non-Beijing strains but had no significant effect on relative transmission indices.

###### Sensitivity analyses of the relative transmission index of *Mycobacterium tuberculosis* lineage, Alberta, Canada, 1991--2007

  Variable                                     Transmission Index          Relative transmission index (95% CI)\*                           
  -------------------------------------------- -------------------- ------ ---------------------------------------- ----------------------- -----------------------
  Cutoff period, y                                                                                                                          
  2                                            0.06                 0.14                                            **0.45 (0.25--0.83)**   0.82 (0.41--1.67)
  3                                            0.09                 0.18                                            **0.50 (0.29--0.89)**   1.04 (0.53--2.06)
  5                                            0.11                 0.33                                            **0.33 (0.17--0.63)**   0.86 (0.41--1.79)
  Overall                                      0.15                 0.39                                            **0.38 (0.26--0.54)**   **0.58 (0.39--0.87)**
  Inclusion of nonpulmonary secondary cases‡   0.07                 0.17                                            **0.42 (0.23--0.74)**   0.70 (0.36--1.36)

\***Boldface** indicates significance (p\<0.05). †Adjusted for sex, age at diagnosis, population group, sputum smear status, lung cavitation and *M. tuberculosis* lineage. ‡Using a 2-year cutoff period.

Discussion
==========

Outbreaks of *M. tuberculosis* Beijing lineage strains in high and low TB incidence settings have had major public health implications ([@R-2-7],[@R-2-24]). Notwithstanding the effect of these outbreaks, we found the transmission of Beijing strains to be similar to that of non-Beijing strains in Alberta, a low TB incidence immigrant-receiving province of Canada. Speculation about the increased transmissibility of Beijing strains also has been refuted in other low incidence immigrant-receiving countries and in The Gambia ([@R-2-8],[@R-2-25]). In South Africa, findings about the transmissibility of Beijing strains have been conflicting ([@R-2-2],[@R-2-26]). The general absence of evidence to suggest that Beijing strains are inherently more transmissible than other *M. tuberculosis* lineages is highly informative for TB prevention and care programs, given the propensity for multidrug-resistant TB among persons infected with Beijing strains ([@R-2-6]--[@R-2-8]).

*M. tuberculosis* is transmitted most frequently when persons with TB have positive sputum acid-fast bacilli results, especially positive results with higher semiquantitative grades, and lung cavitation ([@R-2-27],[@R-2-28]). Consequently, previous findings that Beijing strains are not typically associated with sputum smear positive or cavitary disease ([@R-2-6],[@R-2-29]) accords with reported similarities in the transmission of Beijing and non-Beijing strains. In our study, the infectiousness of Beijing and non-Beijing cases was similar in terms of sputum smear positivity and bacillary load, whereas the likelihood of cavitation was significantly less for Beijing cases.

That Beijing strains have been associated with increased transmission in some settings may reflect geographic variations in virulence phenotypes. In the *M. tuberculosis* complex, evolutionarily modern lineages (including the Beijing lineage) induce weaker immune responses than do ancient lineages, and this response possibly provides modern lineages with a selective advantage in terms of more rapid disease progression and transmission in the human population ([@R-2-30]). An array of virulence phenotypes also have been demonstrated in the more evolutionarily recent subfamily of Beijing strains (i.e., the modern subfamily as characterized by the insertion of IS*6110* in the noise transfer function chromosomal region \[[@R-2-31]\]), including differences in the pathogenic characteristics (and potential transmissibility) of closely related strains in the same sublineage ([@R-2-12],[@R-2-13]). For example, strains in the modern Beijing subfamily have significant variations in their intracellular growth rates and hence significant differences in tumor necrosis factor-α levels ([@R-2-13]). This variation may be of particular relevance because of higher tumor necrosis factor-α levels in the bronchoalveolar lavage fluid of TB patients with large cavities ([@R-2-32]).

To better understand the potential implications of virulence phenotypes, it would be of benefit if future population-based investigations in high and low incidence settings discerned between the disease characteristics and transmissibility of different *M. tuberculosis* subfamilies or sublineages. A post hoc analysis of the IS*6110* RFLP profiles of Beijing strains in this study found that 6 (2.3%) were [\<]{.ul}70% homologous to the profiles of the 19 Beijing reference strains ([@R-2-33]) and may therefore represent atypical/ancient Beijing strains ([@R-2-31]); these 6 isolates had nonclustered IS*6110* RFLP profiles.

In agreement with previous studies ([@R-2-15],[@R-2-18],[@R-2-27]), the transmission of *M. tuberculosis* in our study was lower for older and for foreign-born persons and was unrelated to drug resistance. A deeper exploration into these transmission factors in the current study also demonstrates that these factors are independent of *M. tuberculosis* lineage, at least within the broad categories of Beijing and non-Beijing lineage strains.

TB incidence among foreign-born persons in immigrant-receiving countries has a characteristic and inverse relationship with increased time since arrival ([@R-2-34]). Our findings demonstrate that this characteristic relationship is clearly evident for nonclustered cases that presumably result from the reactivation of latent TB infections acquired before immigration. Clustered Beijing and non-Beijing cases also appear to follow a similar pattern. Despite the occurrence of nearly one quarter of clustered Beijing and non-Beijing cases within the first 2 years after arrival, transmission was not associated with time since arrival, a finding that concurs with a previous study ([@R-2-35]). Nevertheless, time since arrival may still have major implications for the interpopulation transmission of *M. tuberculosis* ([@R-2-35]). Collectively, these findings emphasize the need for screening and prevention activities in foreign-born persons as a critical means of reducing the reactivation of latent TB infection as early after arrival as possible ([@R-2-36]). It also reinforces the need for high-income countries to increase their funding of efforts to expand TB care in high incidence countries ([@R-2-37]).

This study reaffirms that foreign-born persons are not a major source of *M. tuberculosis* transmission (including Beijing strains) despite their high case rates ([@R-2-15],[@R-2-18],[@R-2-21]). Rather, the proportion of nonclustered cases suggests that the reactivation of latent TB infection accounts for 82% of foreign-born case-patients (i.e., 80% and 83% of foreign-born Beijing and non-Beijing case-patients, respectively). The inevitable importation of pathogens, such as Beijing strains, therefore should not be viewed so much as a threat as a challenge. The challenge lies in the host country's resolve to prevent the reactivation of latent TB infection in recently arrived immigrants and in a larger population of aging immigrants while contending with constantly evolving immigration patterns ([@R-2-34]).

The maintenance of a comprehensive provincial TB dataset derived through the amalgamation of TB Registry and mycobacteriology data was crucial for this study and the general evaluation of TB prevention and care in Alberta. The accuracy of strain classification also was enhanced through use of an unambiguous and validated genotyping method ([@R-2-19],[@R-2-20]). Because Alberta is 1 of 4 primary immigrant-receiving provinces in Canada that has a similar immigration pattern as 2 of the other 3 (i.e., Ontario and British Columbia), the study results are anticipated to have national relevance. The generalizability of the study results to other low TB incidence immigrant-receiving countries will be influenced by the degree to which their immigration patterns are similar.

Unavoidable sampling limitations will have produced underestimates in clustering ([@R-2-38]) and affected the transmission indices ([@R-2-39]). Nevertheless, sampling bias was minimized in several ways: use of the provincial TB Registry for case identification; culture confirmation of \>85% of TB cases in Alberta; availability of an expansive study period; and inclusion of 99% of eligible culture-confirmed pulmonary TB cases. Although a common practice in transmission studies, excluding nonpulmonary secondary cases could produce underestimates in clustering and transmission indices. However, sensitivity analyses in this study found the effect of this limitation to be minimal, the overall associations with transmission being unaffected by the inclusion of nonpulmonary secondary cases.

The transmission index used in this study, while advantageous for quantifying recent transmission within an expansive study period ([@R-2-21]), is subject to the same limitations as other TB transmission indices ([@R-2-39]). Overestimates in clustering may have resulted from the common molecular epidemiologic assumption that cases with identical DNA fingerprints were part of a transmission cluster ([@R-2-4],[@R-2-27]). Although bias may have been introduced by excluding 31% of cases from the analysis of recent transmission, the effect on the study results probably is minimal because of the similarities of included and excluded cases. Last, the relatively small number of secondary Beijing cases and Beijing cases among Canadian-born persons in this study limited the ability to comprehensively assess the cross-population transmission of Beijing strains and the strain-specific transmission patterns in Canadian-born Aboriginal peoples.

This study demonstrated that Beijing strains are not independently associated with increased clustering or a larger number of secondary cases than non-Beijing strains in a setting with comprehensive and effective TB prevention and care practices ([@R-2-40]). Combined with the uncommon transmission of *M. tuberculosis* by foreign-born persons in this and other studies that led to disease ([@R-2-15],[@R-2-18]), there appears to be little cause for concern about the importation and subsequent transmission of Beijing strains in low TB incidence immigrant-receiving settings.

###### Technical Appendix

Kaplan-Meier estimates of the probability of an identical DNA fingerprint pattern match in respiratory tuberculosis cases in Alberta, Canada, 1991--2007.
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1\. You are seeing family of 5 who emigrated from China one year ago. The father of the family was recently diagnosed with pulmonary tuberculosis (TB), and you are worried about the potential spread of the infection, particularly with virulent strains of *Mycobacterium tuberculosis*. What should you consider in general regarding the epidemiology of the Beijing lineage of *M. tuberculosis*?

A. It accounts for 13% of all TB strains globally

B. It accounts for less than 2% of cases of TB in immigrant-receiving countries with low rates of infection

C. It is rarely resistant to treatment

D. The Beijing strain is less virulent compared with other TB strains in animal models

**2. Which of the following characteristics was most associated with TB infection with the Beijing strains in the current study?**

A. Higher proportion of foreign-born patients

B. Younger age

C. More likely to have a positive sputum smear

D. Higher rates of drug resistance

**3. What should you consider regarding the transmission of Beijing vs non-Beijing strains of TB in the current study?**

A. The Beijing strains were associated with higher rates of clustered cases

B. The Beijing strains were associated with similar rates of clustered cases compared with non-Beijing strains

C. The Beijing cases were only more likely to be clustered among foreign-born patients

D. The Beijing cases were only more likely to be clustered among drug-resistant strains

**4. Which of the following factors was most positively associated with a higher rate of secondary cases of TB in the current study?**

A. Beijing lineage

B. Age over 64 years in the index case

C. Positive sputum smear in the index case

D. Foreign-born patient in the index case
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